Shanghai INT Medical Instruments Co., Ltd. (HKG: 1501)

Market Cap	4.95B
Revenue (ttm)	865.39M
Net Income (ttm)	179.64M
Shares Out	175.11M
EPS (ttm)	1.09
PE Ratio	25.98
Forward PE	22.15
Dividend	0.30 (1.05%)
Ex-Dividend Date	May 30, 2024

Volume	5,800
Open	27.85
Previous Close	27.80
Day's Range	27.55 - 28.25
52-Week Range	24.65 - 29.40
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 19, 2024

About Shanghai INT Medical Instruments

Shanghai INT Medical Instruments Co., Ltd. engages in the research and development, manufacture, and sale of cardiovascular interventional medical devices in Mainland China, Europe, the United States, and internationally. The company offers digital inflation devices; cardiac valves balloon inflation catheter; guiding catheter used to provide a channel for introducing balloon catheter, guidewire or other treatment devices; micro catheter to support the placement of guide wires; guidewire; angiography catheter used to inject and infuse contrast m...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2006
• Employees: 1,567
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1501

Financial Performance

In 2023, Shanghai INT Medical Instruments's revenue was 752.84 million, an increase of 28.50% compared to the previous year's 585.88 million. Earnings were 151.88 million, an increase of 16.70%.

Financial numbers in CNY